Collectively, these findings indicate that TCN1 promotes pancreatic cancer malignancy by activating DUOX2-dependent signaling, which drives ROS generation and facilitates aggressive tumor behavior. The gene discussed is DUOX2; the disease is pancreatic neoplasm.